Apyx Medical Corporation (APYX)
Apyx Medical Corporation (APYX) is a healthcare company (medical devices) based in the United States. The share price is $2.57, down 3.02% on the day, which values the company at $108.26M. Price as of 17 Nov 2026, 17:34 UTC, from Yahoo Finance.
Key facts
- Share price
- $2.57−3.02% today
- Market value
- $108.26M
- Funk Score
- 40/100
- Against its own history
- About its usual priceusual price $2.45
- 200-week average
- $2.746% below
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Apyx Medical Corporation in more detail
APYX trades at -13.5× next year's expected earnings, 1.8× sales. Measured against its own history, the price is 5% above what its usual multiples would imply ($2.45) — about its usual price. It sits 6% below its 200-week average of $2.74.
Over the last five fiscal years Apyx Medical Corporation has compounded revenue 13.8% a year. Its Funk Score is 40 out of 100 (financial strength 3.1, profitability 2.2, growth 5.7, value 5.0, each out of 10).
Worth checking: Altman Z in the distress zone; Share count keeps rising.
1 of the superinvestors tracked here hold APYX, including Murray Stahl (0.0% of the portfolio).
Superinvestors holding APYX
1 of the investors tracked here report a position in their latest 13F filing.
- Murray Stahl Horizon Kinetics0.01% of portfolio · $1.1M · trimmed · Q3 2026
Apyx Medical Corporation (APYX): questions and answers
What is APYX's PEG ratio?
Apyx Medical Corporation's PEG ratio is 0.59 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.
What is Apyx Medical Corporation's market cap?
Apyx Medical Corporation is valued at $108.26M at a share price of $2.57.
Is APYX overvalued or undervalued?
Against its own history, APYX is about its usual price: the price is 5% above the $2.45 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.
Is APYX above its 200-week moving average?
No. APYX is 6.3% below its 200-week average of $2.74. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Apyx Medical Corporation growing?
Over the last five fiscal years Apyx Medical Corporation's revenue grew 13.8% a year; over ten years revenue grew 6.0% a year.
Does APYX pay a dividend?
Apyx Medical Corporation does not currently pay a regular dividend.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Apyx Medical Corporation (APYX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/APYX
Underlying data: Yahoo Finance; company filings with the SEC.